Targeted Cancer Therapy

Showing all 2 results

Gefinorm

Gefitinib

250mg

Film Coated Tablet

Indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
×
Gefinorm

Generic Name:
Gefitinib

Available In:
250mg

Dosage Form:
Film Coated Tablet

Indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test

Reminder: Food, Drugs, Devices, and Cosmetics Act prohibits dispensing w/o prescription.
Hertraz

Trastuzumab

150mg

Powder for Concentrate for Solution for Infusion

For the treatment of adult patients with HER2 positive metastatic breast cancer (MBC).
×
Hertraz

Generic Name:
Trastuzumab

Available In:
150mg

Dosage Form:
Powder for Concentrate for Solution for Infusion

For the treatment of adult patients with HER2 positive metastatic breast cancer (MBC).

Reminder: Food, Drugs, Devices, and Cosmetics Act prohibits dispensing w/o prescription.